Stress / Sleep
Clinical positioning
Physician-directed neuro-calming support in stress, sleep-rest balance and emotional resilience protocols.
Clinical use lens
Calm-first supportive-care routineUse for stress load, sleep disruption and emotional-rest support; in oncology protocol, position only as symptom-burden and quality-of-life support, not cancer-directed therapy.
Protocol mapping
Indication fit
Stress support
Restful sleep
Mental calm
Emotional balance
Why doctors reach for it
Clinical highlights
✦Neuro-calming: stress, hyperarousal and emotional balance support
✓Sleep-rest: supports calm night routine without sedative claims
→Lipid base: ghrita supports lipophilic botanical delivery
How it is positioned to work
Mechanism map
1Neuro-calming support through Brahmi, Jatamansi and Vijaya-oriented pathways
2Ghee/lipid base supports delivery of lipophilic botanical actives
3Stress-adaptation and sleep-rest balance positioning for restorative routines
Physician-directed dosing
Administration & dosing
X
Dose framework
X = body weight in kilogramsFirst dose
≤ X/2 mgGrade-guided range
X–10X mg
≤ X/2 mgGrade-guided range
X–10X mg
First dose must never exceed X/2 mg total cannabinoids (equivalent to ≤0.5 mg/kg when X is body weight in kg). Further titration may move within X to 10X mg total cannabinoids only after tolerance and response review.
1–10
Indication grade
- Grade 1–10: set by indication severity, pain/inflammation burden, ESR, CRP and symptom trajectory.
- Adjust for age, frailty, secondary conditions, hepatic/renal risk, concurrent medicines and tolerance.
- Use follow-up response to hold, increase, reduce or discontinue.
↗
Titration model
- Incremental: gradual upward titration until response / tolerability.
- Incremental–decremental: step up, then reduce to minimum effective maintenance.
- Microdosing: very low divided exposure for sensitive, elderly or polypharmacy patients.
Rx
Administration
- Oral / sublingual / with suitable carrier as per physician direction and product format.
- Prefer consistent timing; document relation to food, sleep, pain peak, appetite or protocol goal.
- Document dose, route, time, food/carrier, indication grade, ESR/CRP or relevant markers, adverse effects and follow-up plan.
- Monitor sedation, dizziness, GI tolerance, cognition, drug interactions and functional response.
Full titration walkthrough: physician dosage guide.
In-clinic use
Doctor use notes & safety boundary
Doctor use notes
- Start low and titrate by clinical context, tolerability and symptom severity.
- Track response, co-medications, sedation, GI tolerance and follow-up outcome.
- Document dose, timing, duration, indication and review plan.
Safety boundary
- For registered medical practitioners only
- Select dose by clinical context and tolerability
- Monitor sedation, interactions and follow-up response
- Not for direct patient promotion
5 actives
Formula / ingredients
| Ingredient | Botanical / base | Part | Qty |
|---|---|---|---|
| Brahmi | Bacopa monnieri | Wh. Plant Juice | 200ml (62.5%) |
| Vacha | Acorus calamus | Rhizome | 10gms (3.125%) |
| Jatamamsi | Nardostachys jatamansi | Rhizome | 10gms (3.125%) |
| Goghrita (Cow Ghee) | Cow’s ghee | — | 80ml (25%) |
| Bhang (Vijaya) | Cannabis sativa Linn | Leaf | 20gms (6.25%) |
Clinic packs
Pack / MRP
| Pack | Strength | MRP |
|---|---|---|
| 10 ml | 1000mg total cannabinoids≈ 5 mg/drop | ₹899 |
| 30 ml | 3000mg total cannabinoids≈ 5 mg/drop | ₹2,600 |
Pack / MRP summary: 10 ml ₹899 (1000mg) · 30 ml ₹2,600 (3000mg)
4 source links
Audited research links
| Audited reference fit | Clinical logic | Source |
|---|---|---|
| Brahmi / Bacopa monnieri ✓ Calm/sleep checkedPubMed / PMIDScientific context Brahmi (Bacopa monnieri): GABA Modulation, Cortisol Reduction, Cognition | Cognition, stress and GABA/cortisol logic | Open ↗ |
| Vacha / Acorus calamus ✓ Scientific fit checkedPubMed / PMIDScientific context Role of Vacha (Acorus calamus Linn.) in Neurological and Metabolic Disorders | Traditional medhya / neuro-support herb; neurological review-level evidence | Open ↗ |
| Jatamansi / Nardostachys jatamansi ✓ Calm/sleep checkedPubMed / PMIDScientific context Nardostachys jatamansi (Jatamansi): Anxiolytic via GABA Modulation | Anxiolytic / GABA modulation reference | Open ↗ |
| CBD / cannabinoids ✓ Calm/sleep checkedPubMed / PMIDClinical context Cannabidiol as a Potential Treatment for Anxiety Disorders | Anxiety-disorder mechanism and clinical research context | Open ↗ |
Educational use only. Doctor-facing scientific aid only. Research links are mapped for ingredient rationale, mechanism, clinical context and safety boundaries. This brochure does not replace diagnosis, standard-of-care treatment, regulatory prescribing rules or clinical monitoring. See our legal & medical disclaimer and editorial policy.
Same protocol
